The Global Botulinum Toxin Market is Projected to Reach $6.6 Billion by 2022

Growing Prominence of Non-Invasive Cosmetic Treatments to Drive Growth in the Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, market size and demand forecasts on the global Botulinum Toxin market. The global Botulinum Toxin market is projected to reach $6.6 billion by 2022, driven by expanding range of therapeutic indications and the rising demand for non-invasive cosmetic treatment solutions.

Botulinum Toxin (BTX), a protein produced by Clostridium Botulinum bacterium, possesses muscle-relaxing properties due to its ability to arrest the release of acetylcholine. Rising incidences of movement related disorders and increasing number of patients with muscle spasms is primarily responsible for the strong evolution of the market over the years. Further, new clinical indications of BTX such as in treatment of nystagmus, stridor, palatal myoclonus, scoliosis, co-spasms following brachial plexus lesions (birth related), and gait freezing (Parkinson), have helped strengthen growth in the market. While advancements in research and development of botulinum toxin have revolutionized medical and therapeutic uses over the past few decades, the largest opportunity has emerged from the facial aesthetics space. The combination of scientific benefits and mega trends such as rising consumer disposable income, increased per capita spending on appearance-enhancing products, growing social acceptance of aesthetic medical procedures, and easy product accessibility, have led to the increased use of botulinum toxin in aesthetic applications.

Driven by the growing acceptance of facial injectables, especially BTX, for improving facial aesthetics among adults and approval for using therapeutic BTX in the treatment of an expanded range of indications, the global market for botulinum toxin is expected to make rapid strides in the ensuing years. With cosmetic indications for BTX ranging from facial wrinkles to eyebrow furrows, the rapidly aging population across the world is emerging as a strong demographic driver of growth for appearance-enhancing and age-defying skin cosmetic treatments. The increasing emphasis on retaining youthful health and appearance, and rising demand for non-invasive cosmetic treatments are expected to fuel growth in the cosmetic BTX market. The market is being favorably impacted by the results of clinical evaluations of product benefits, with such clinical trials not only helping commercialize new products but also boosting physician and patient confidence in claimed product benefits, thus encouraging growth in the number of BTX-based treatment regimens.

As stated by the new market research report on Botulinum Toxin, the United States represents the largest regional market worldwide. While developed regions such as the US and Europe are likely to remain the dominant markets for Botulinum toxin in the years ahead, future growth will be driven by growing demand from the emerging nations of Asia-Pacific, Latin America, and Eastern Europe. Asia-Pacific is poised to record the fastest CAGR of 14.2% over the analysis period. Growing affluence of the expanding middle class population, low per capita spending on BTX products, coupled with rising disposable income levels, aggressive retail marketing, rising health awareness levels, and growing consciousness about looks and appearance make the region a highly lucrative market for BTX.

Major players profiled in the report include Allergan Plc, Ipsen Group, Medy-Tox Inc., Merz Pharma GmbH & Co. KGaA, Metabiologics Inc., Revance Therapeutics Inc. and US WorldMeds, among others.

The research report titled “Botulinum Toxin: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for all major geographic markets such as the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. The report analyzes the market for Botulinum Toxin by the following segments - Cosmetic Applications and Therapeutic Applications.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.